Search in:

Clinical Ophthalmology Volume 12, 2018 - Issue

Submit an article Journal homepage

Open access

116

Views

CrossRef citations to date

Altmetric

Clinical Trial Report

Post-marketing surveillance study of the safety of dexamethasone intravitreal implant in patients with retinal vein occlusion or noninfectious posterior segment uveitis

Adnan Tufail1 Moorfields Eye Hospital, London, UK, [email protected]Correspondence[email protected]

Sue Lightman1 Moorfields Eye Hospital, London, UK, [email protected]

Ahmed Kamal2 Aintree University Hospital, Liverpool, UK

Uwe Pleyer3 University Eye Hospital, Uveitis Center, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt University Berlin, and Berlin Institute of Health, Berlin, Germany

Nuria María Gajate Paniagua4 University Hospital of Burgos, Burgos, Spain

Corrine Dot5 Department of Ophthalmology, Desgenettes Military Hospital, Lyon, France;6 French Military Health Service Academy, Val de Grâce, Paris, France

Xiao-Yan Li7 Allergan Plc, Irvine, CA, USA

Jenny Jiao7 Allergan Plc, Irvine, CA, USA

Jean Lou7 Allergan Plc, Irvine, CA, USA

Yehia Hashad7 Allergan Plc, Irvine, CA, USA

& On behalf of the CONSTANCE Study Group show all

Pages 2519-2534 | Published online: 06 Dec 2018

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

WhitcupSMRobinsonMRDevelopment of a dexamethasone intravitreal implant for the treatment of noninfectious posterior segment uveitisAnn N Y Acad Sci2015135811226200808
PubMed Web of Science ®Google Scholar
HoMLiuDTLamDSJonasJBRetinal vein occlusions, from basics to the latest treatmentRetina201636343244826716954
PubMed Web of Science ®Google Scholar
DeobhaktaAChangLKInflammation in retinal vein occlusionInt J Inflam2013201343841223653882
PubMedGoogle Scholar
HallerJADugelPWeinbergDVChouCWhitcupSMEvaluation of the safety and performance of an applicator for a novel intravitreal dexamethasone drug delivery system for the treatment of macular edemaRetina2009291465118827732
PubMed Web of Science ®Google Scholar
Chang-LinJEAttarMAcheampongAAPharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implantInvest Ophthalmol Vis Sci2011521808620702826
PubMed Web of Science ®Google Scholar
CampochiaroPAHafizGMirTAPro-permeability factors after dexamethasone implant in retinal vein occlusion; the Ozurdex for Retinal Vein Occlusion (ORVO) studyAm J Ophthalmol20151602313321e1925908486
PubMed Web of Science ®Google Scholar
Rezar-DreindlSEibenbergerKPollreiszAEffect of intravitreal dexamethasone implant on intra-ocular cytokines and chemokines in eyes with retinal vein occlusionActa Ophthalmol2017952e119e12727417275
PubMed Web of Science ®Google Scholar
HallerJABandelloFBelfortRJrRandomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusionOphthalmology2010117611341146e320417567
PubMed Web of Science ®Google Scholar
LowderCBelfortRLightmanSDexamethasone intravitreal implant for noninfectious intermediate or posterior uveitisArch Ophthalmol2011129554555321220619
PubMed Web of Science ®Google Scholar
AllerganOzurdex Prescribing Information2010 Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022315s010lbl.pdfAccessed September 10, 2017
Google Scholar
HallerJABandelloFBelfortRJrDexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study resultsOphthalmology2011118122453246021764136
PubMed Web of Science ®Google Scholar
KorobelnikJFKodjikianLDelcourtCTwo-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in FranceGraefes Arch Clin Exp Ophthalmol2016254122307231827286894
PubMed Web of Science ®Google Scholar
MalclèsADotCVoirinNSafety of intravitreal dexamethasone implant (Ozurdex): the SAFODEX study. Incidence and risk factors of ocular hypertensionRetina20173771352135927768641
PubMed Web of Science ®Google Scholar
CaponeASingerMADodwellDGEfficacy and safety of two or more dexamethasone intravitreal implant injections for treatment of macular edema related to retinal vein occlusion (Shasta study)Retina201434234235123846381
PubMed Web of Science ®Google Scholar
LamWCAlbianiDAYoganathanPReal-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME studyClin Ophthalmol201591255126826203215
PubMed Web of Science ®Google Scholar
KolarPRisk factors for central and branch retinal vein occlusion: a meta-analysis of published clinical dataJ Ophthalmol2014201472478025009743
PubMed Web of Science ®Google Scholar
BoyerDSYoonYHBelfortRThree-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edemaOphthalmology2014121101904191424907062
PubMed Web of Science ®Google Scholar
MalclèsADotCVoirinNReal-life study in diabetic macular edema treated with dexamethasone implant: the RELDEX studyRetina201737475376027471826
PubMed Web of Science ®Google Scholar
KhuranaRNBansalASChangLKPalmerJDWuCWielandMRProspective evaluation of a sustained-release dexamethasone intravitreal implant for cystoid macular edema in quiescent uveitisRetina20173791692169927893624
PubMed Web of Science ®Google Scholar
Tomkins-NetzerOTaylorSRBarATreatment with repeat dexamethasone implants results in long-term disease control in eyes with noninfectious uveitisOphthalmology201412181649165424650556
PubMed Web of Science ®Google Scholar
PleyerUKlamannMLaurentTJFast and successful management of intraocular inflammation with a single intravitreal dexamethasone implantOphthalmologica2014232223229
Web of Science ®Google Scholar
RezkallahAKodjikianLMalclèsADotCDEX implant intravitreal injection, sustained intraocular hypertension, and steroid-induced glaucoma in patients with no risk factorsGraefes Arch Clin Exp Ophthalmol2018256121922028801709
PubMed Web of Science ®Google Scholar
MaturiRKPollackAUyHSIntraocular pressure in patients with diabetic macular edema treated with dexamethasone intravitreal implant in the 3-year MEAD studyRetina20163661143115226871523
PubMed Web of Science ®Google Scholar
MeyerCHMichelsSRodriguesEBIncidence of rhegmatogenous retinal detachments after intravitreal antivascular endothelial factor injectionsActa Ophthalmol2011891707521176118
PubMed Web of Science ®Google Scholar
BezatisASpitalGHöhnFFunctional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up – the SOLO studyActa Ophthalmol2013915e340e34723638803
PubMed Web of Science ®Google Scholar
Fassbender AdeniranJMJusufbegovicDSchaalSCommon and rare ocular side-effects of the dexamethasone implantOcul Immunol Inflamm201725683484027379861
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Post-marketing surveillance study of the safety of dexamethasone intravitreal implant in patients with retinal vein occlusion or noninfectious posterior segment uveitis

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Post-marketing surveillance study of the safety of dexamethasone intravitreal implant in patients with retinal vein occlusion or noninfectious posterior segment uveitis

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date